Annual EBIT
-$76.20 M
+$14.13 M+15.64%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual earnings before interest & taxes is -$76.20 million, with the most recent change of +$14.13 million (+15.64%) on December 31, 2023.
- During the last 3 years, BOLT annual EBIT has fallen by -$27.01 million (-54.93%).
- BOLT annual EBIT is now -555.22% below its all-time high of -$11.63 million, reached on December 31, 2018.
Performance
BOLT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$16.44 M
+$2.59 M+13.60%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly earnings before interest & taxes is -$16.44 million, with the most recent change of +$2.59 million (+13.60%) on September 30, 2024.
- Over the past year, BOLT quarterly EBIT has increased by +$2.59 million (+13.60%).
- BOLT quarterly EBIT is now -88.03% below its all-time high of -$8.74 million, reached on March 31, 2020.
Performance
BOLT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$72.33 M
+$1.74 M+2.35%
September 30, 2024
Summary
- As of February 8, 2025, BOLT TTM earnings before interest & taxes is -$72.33 million, with the most recent change of +$1.74 million (+2.35%) on September 30, 2024.
- Over the past year, BOLT TTM EBIT has increased by +$1.74 million (+2.35%).
- BOLT TTM EBIT is now -660.84% below its all-time high of -$9.51 million, reached on December 31, 2019.
Performance
BOLT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BOLT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.6% | +13.6% | +2.4% |
| 3 y3 years | -54.9% | +13.6% | +2.4% |
| 5 y5 years | -555.2% | +13.6% | +2.4% |
BOLT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.9% | at high | +39.3% | at high | +26.4% |
| 5 y | 5-year | -146.0% | +17.9% | -88.0% | +39.3% | -660.8% | +26.4% |
| alltime | all time | -555.2% | +17.9% | -88.0% | +39.3% | -660.8% | +26.4% |
Bolt Biotherapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.44 M(-13.6%) | -$72.33 M(-2.3%) |
| Jun 2024 | - | -$19.03 M(+11.4%) | -$74.07 M(-1.1%) |
| Mar 2024 | - | -$17.09 M(-13.5%) | -$74.87 M(-1.7%) |
| Dec 2023 | -$76.20 M(-15.6%) | -$19.77 M(+8.7%) | -$76.20 M(-1.6%) |
| Sep 2023 | - | -$18.18 M(-8.3%) | -$77.47 M(-5.1%) |
| Jun 2023 | - | -$19.83 M(+7.7%) | -$81.63 M(-3.8%) |
| Mar 2023 | - | -$18.41 M(-12.5%) | -$84.86 M(-6.0%) |
| Dec 2022 | -$90.32 M | -$21.04 M(-5.8%) | -$90.32 M(-6.3%) |
| Sep 2022 | - | -$22.35 M(-3.1%) | -$96.36 M(-1.2%) |
| Jun 2022 | - | -$23.06 M(-3.4%) | -$97.54 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$23.88 M(-11.8%) | -$98.24 M(+5.9%) |
| Dec 2021 | -$92.79 M(+88.7%) | -$27.07 M(+15.1%) | -$92.79 M(+12.3%) |
| Sep 2021 | - | -$23.53 M(-1.0%) | -$82.64 M(+15.6%) |
| Jun 2021 | - | -$23.76 M(+29.0%) | -$71.51 M(+21.5%) |
| Mar 2021 | - | -$18.43 M(+8.9%) | -$58.86 M(+19.7%) |
| Dec 2020 | -$49.18 M(+58.8%) | -$16.92 M(+36.4%) | -$49.18 M(+17.8%) |
| Sep 2020 | - | -$12.40 M(+11.7%) | -$41.77 M(+42.2%) |
| Jun 2020 | - | -$11.11 M(+27.0%) | -$29.36 M(+60.9%) |
| Mar 2020 | - | -$8.74 M(-8.0%) | -$18.25 M(+92.0%) |
| Dec 2019 | -$30.97 M(+166.3%) | -$9.51 M | -$9.51 M |
| Dec 2018 | -$11.63 M | - | - |
FAQ
- What is Bolt Biotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual EBIT year-on-year change?
- What is Bolt Biotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly EBIT year-on-year change?
- What is Bolt Biotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics TTM EBIT year-on-year change?
What is Bolt Biotherapeutics annual earnings before interest & taxes?
The current annual EBIT of BOLT is -$76.20 M
What is the all time high annual EBIT for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual earnings before interest & taxes is -$11.63 M
What is Bolt Biotherapeutics annual EBIT year-on-year change?
Over the past year, BOLT annual earnings before interest & taxes has changed by +$14.13 M (+15.64%)
What is Bolt Biotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BOLT is -$16.44 M
What is the all time high quarterly EBIT for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly earnings before interest & taxes is -$8.74 M
What is Bolt Biotherapeutics quarterly EBIT year-on-year change?
Over the past year, BOLT quarterly earnings before interest & taxes has changed by +$2.59 M (+13.60%)
What is Bolt Biotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BOLT is -$72.33 M
What is the all time high TTM EBIT for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high TTM earnings before interest & taxes is -$9.51 M
What is Bolt Biotherapeutics TTM EBIT year-on-year change?
Over the past year, BOLT TTM earnings before interest & taxes has changed by +$1.74 M (+2.35%)